RxSight, Inc. (RXST)

NGM – Real vaqt narxi. Valyuta: USD

5.52

-0.18 (-3.16%)

Yopilishda: May 12, 2026, 4:00 PM EDT

09.05.2026

RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript

06.05.2026

RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

RxSight, Inc. (RXST) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.03 per share a year ago.

06.05.2026

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026.

29.04.2026

RxSight, Inc. to Present at the Bank of America Healthcare Conference

ALISO VIEJO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., today announced plans to participate in the upcoming Bank of America Healthcare Conference. Management is scheduled to participate in a fireside chat on Wednesday, May 13, 2026, at 3:00 p.m. Pacific Time. A live and archived webcast of the presentation will be available on the company's investor relations website at https://investors.rxsight.com/.

22.04.2026

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

ALISO VIEJO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the first quarter after the market close on Wednesday, May 6, 2026. The company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

08.04.2026

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

WASHINGTON, April 08, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced, in advance of the 2026 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, that over 300,000 Light Adjustable Lens® (LAL®) implants have been performed since launch, marking a significant milestone in the company's pursuit to make customized vision correction widely available to patients.

02.04.2026

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

ALISO VIEJO, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming 25th Annual Needham Virtual Healthcare Conference. Management is scheduled to participate in a fireside chat on Thursday, April 16, 2026, at 8:00 a.m. Pacific Time. A live and archived webcast of the presentation will be available on the company's investor relations website at https://investors.rxsight.com/.

Videolar

No Data

There is no data to display

Reytinglar oshishi / pasayishi

Ticker	Tashkilot	Reyting o‘zgarishi	Maqsadli narx	Sana
RXST	Morgan Stanley	Equal Weight	undefined >> $9	July 15th 2025
RXST	Jefferies	Hold	undefined >> $9	July 10th 2025
RXST	Oppenheimer	Perform	undefined >> undefined	July 9th 2025
RXST	Wells Fargo	Equal Weight	undefined >> $9	July 9th 2025
RXST	BTIG Research	Neutral	undefined >> undefined	July 9th 2025
RXST	Wells Fargo	Overweight	undefined >> $25	May 19th 2025
RXST	Piper Sandler	Neutral	undefined >> $18	April 15th 2025
RXST	UBS	Neutral	undefined >> $16	April 9th 2025

Press-relizlar

06.05.2026

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

ALISO VIEJO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended March 31, 2026.

08.04.2026

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

02.04.2026

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

22.01.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

RxSight, Inc. (RXST)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

RxSight, Inc. (RXST)

RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript

RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RxSight, Inc. to Present at the Bank of America Healthcare Conference

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript

RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RxSight, Inc. to Present at the Bank of America Healthcare Conference

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

Search stocks

RxSight, Inc. (RXST)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

RxSight, Inc. (RXST)

RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript

RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RxSight, Inc. to Present at the Bank of America Healthcare Conference

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

RxSight, Inc. (RXST) Q1 2026 Earnings Call Transcript

RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RxSight, Inc. to Present at the Bank of America Healthcare Conference

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

Videolar

No Data

Reytinglar oshishi / pasayishi

Press-relizlar

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST